| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_10e4b1416c6e66e0ade5429212414964 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07F9-6506 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07F9-6506
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-675 |
| filingDate |
2004-07-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6b55e4f4584c9bce5941fe0d477e82ab
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5419ebfa5e24854e2502d9ca6deb3248 |
| publicationDate |
2005-08-31-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
EP-1567533-A2 |
| titleOfInvention |
Zoledronic acid crystal forms, zoledronate sodium salt crystal forms, amorphous zoledronate sodium salt, and processes for their preparation |
| abstract |
The invention relates to polymorphs of zoledronic acid and zolidronate sodium salts, amorphous zoledronate sodium salts, processes for making the polymorphs and amorphous zoledronate sodium salt and pharmaceutical compositions containing the polymorphs and amorphous zoledronate sodium salt |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10195218-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10323052-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10093691-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8933057-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9340565-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8399023-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10519176-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9334296-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9169279-B2 |
| priorityDate |
2003-07-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |